Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butantan Surfactant in Preterm Infants with Respiratory Distress Syndrome
NCT02305160Phase 3Completed
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2005
- Primary completion
- May 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Butantan Surfactant in respiratory distress syndrome (RDS) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Mortality rate at 72 hours. Started Apr 2005; status: completed.
02
Drugs
Butantan Surfactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT02305160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02305160.